Table 5.
Kinase analysis of TIMP‐1‐mediated effects.
| Tyrosine kinases | Serine/threonine kinases |
|---|---|
| 1 Insulin receptor (INSR) | 1 Spleen tyrosine kinase (SYK) |
| 2 Insulin‐like growth factor 1 receptor (IGF1R) | 2 B lymphocyte kinase (BLK) |
| 3 Insulin receptor‐related protein (INSRR) | 3 Hepatocyte growth factor receptor (MET) |
| 4 NT‐3 growth factor receptor (NTRK2) | 4 Fibroblast growth factor receptor 3 (FGFR3) |
| 5 High‐affinity nerve growth factor receptor (NTRK1) | 5 Abelson murine leukemia viral oncogene homolog 1 (ABL) |
| 6 v‐Kit Hardy–Zuckerman 4 feline sarcoma viral oncogene homolog (c‐Kit) | 6 Receptor tyrosine‐protein kinase erbB‐3 (ERBB3) |
| 7 Fibroblast growth factor receptor 4 (FGFR4) | 7 Serine/arginine repetitive matrix protein 1 (SRMS) |
| 8 Proto‐oncogene tyrosine‐protein kinase Src (SRC) | 8 Gardner–Rasheed feline sarcoma viral (v‐fgr) oncogene homolog (FGR) |
| 9 Tyrosine‐protein kinase Lyn (LYN) | 9 Macrophage‐stimulating protein receptor (MST1R/RON) |
| 10 Lymphocyte‐specific protein tyrosine kinase (LCK) | 10 Related to receptor tyrosine kinase (RYK) |